RELATIVE CONTRIBUTION OF FASTING PLASMA AND POSTPRANDIAL GLUCOSE TO HBA1C AND TIR IN PEOPLE WITH T1D ON BASAL-BOLUS INSULIN THERAPY

被引：0
|
作者：
De Oliveira, C. Piras [1 ]
Dellva, M. A. [1 ]
Bue-Valleskey, J. [1 ]
Chang, A. [1 ]
Chigutsa, F. [1 ]
Liao, B. [1 ]
机构：
[1] Eli Lilly & Co, Diabet, Indianapolis, IN 46285 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP053 / #3
引用
收藏
页码：A102 / A102
页数：1
相关论文
共 50 条
  • [1] Relative Contribution of Fasting Plasma and Postprandial Glucose to HbAlc and TIR in People with T1D on Basal-Bolus Insulin Therapy
    De Oliveira, Carolina Piras
    Dellva, Mary A.
    Bue-Valleskey, Juliana M.
    Chang, Annette M.
    Chigutsa, Farai B.
    Liao, Birong
    [J]. DIABETES, 2021, 70
  • [2] Contribution of fasting and postprandial plasma glucose to HbA1c in people with type 2 diabetes on basal-bolus insulin: a meta-analysis of insulin lispro clinical trials
    Liao, B.
    Chen, Y.
    Chigutsa, F.
    de Oliveira, C. Piras
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S332 - S332
  • [3] Contribution of fasting and postprandial plasma glucose to HbA1c
    Ollerton, RL
    Luzio, SD
    Owens, DR
    [J]. DIABETIC MEDICINE, 2005, 22 (07) : 954 - 955
  • [4] A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1C
    Jing Ma
    Hua He
    Xiaojie Yang
    Dawei Chen
    Cuixia Tan
    Li Zhong
    Qiling Du
    Xiaohua Wu
    Yunyi Gao
    Guanjian Liu
    Chun Wang
    Xingwu Ran
    [J]. Nutrition & Diabetes, 11
  • [5] A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1C
    Ma, Jing
    He, Hua
    Yang, Xiaojie
    Chen, Dawei
    Tan, Cuixia
    Zhong, Li
    Du, Qiling
    Wu, Xiaohua
    Gao, Yunyi
    Liu, Guanjian
    Wang, Chun
    Ran, Xingwu
    [J]. NUTRITION & DIABETES, 2021, 11 (01)
  • [6] What is the real contribution of fasting plasma glucose and postprandial glucose in predicting HbA1c and overall blood glucose control?
    Caputo, S
    Pitocco, D
    Ruotolo, V
    Ghirlanda, G
    [J]. DIABETES CARE, 2001, 24 (11) : 2011 - 2011
  • [7] Reduced Mean Glucose and Glycemic Variability with Coadministration of Basal-Bolus Pramlintide and Insulin in Type 1 Diabetes (T1D)
    Riddle, Matthew C.
    Nahra, Rajaa
    Han, Jenny
    Hompesch, Marcus
    Huffman, David
    Strange, Poul
    Ohman, Peter
    [J]. DIABETES, 2017, 66 : A298 - A298
  • [8] Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c
    Bastyr, EJ
    Stuart, CA
    Brodows, RG
    Schwartz, S
    Graf, CJ
    Zagar, A
    Robertson, KE
    [J]. DIABETES CARE, 2000, 23 (09) : 1236 - 1241
  • [9] Insulin detemir reduces the risk of hypoglycaemia at all levels of HbA1c compared to NPH insulin in the context of basal-bolus therapy for type 1 diabetes
    Jones, DR
    Kim, H
    Heller, S
    Clauson, P
    [J]. DIABETOLOGIA, 2005, 48 : A92 - A93
  • [10] Screening diabetes with HbA1c and fasting plasma glucose
    Yang, T.
    Yu, D.
    Zhou, H.
    Zhu, G.
    [J]. DIABETOLOGIA, 2010, 53 : S158 - S158
12345